CXCL1 and melanoma: Our results, demonstrating that CXCL1 serum levels were significantly reduced in B16/PTGS2Δ melanoma bearing mice, are completely in line with these findings and further support the ability of PTGS2 to regulate CXCL1 secretion in melanoma.